-transparent.png){kind=logo}
We compared auranofin (AF) in a single blind multi-centre study with gold sodium thiomalate and D-penicillamine in the treatment of rheumatoid arthritis. Adult patients with disease duration 6-60 months without previous treatment with gold salts with persistent active disease, were included. Thirty-nine patients, 13 in each treatment group, have so far been entered. Cumulative toxicity data and some results of efficacy assessments in those completing 9 months of treatment are presented. AF is very well tolerated, judgment concerning efficacy must await the end of the trial.
Related Publications
D Barraclough, and
A Brook, and
P Brooks, and
K Boyden, and
D Thomas, and
K Tymms
December 1990,
Clinical rheumatology,
D Barraclough, and
A Brook, and
P Brooks, and
K Boyden, and
D Thomas, and
K Tymms
February 1990,
Ryumachi. [Rheumatism],
D Barraclough, and
A Brook, and
P Brooks, and
K Boyden, and
D Thomas, and
K Tymms
February 1985,
The Journal of rheumatology,
D Barraclough, and
A Brook, and
P Brooks, and
K Boyden, and
D Thomas, and
K Tymms
January 1985,
Scandinavian journal of rheumatology,
D Barraclough, and
A Brook, and
P Brooks, and
K Boyden, and
D Thomas, and
K Tymms
February 1988,
Klinische Wochenschrift,
D Barraclough, and
A Brook, and
P Brooks, and
K Boyden, and
D Thomas, and
K Tymms
January 1982,
The Journal of rheumatology. Supplement,
D Barraclough, and
A Brook, and
P Brooks, and
K Boyden, and
D Thomas, and
K Tymms
September 1987,
Clinical rheumatology,
D Barraclough, and
A Brook, and
P Brooks, and
K Boyden, and
D Thomas, and
K Tymms
March 1984,
Clinical rheumatology,
D Barraclough, and
A Brook, and
P Brooks, and
K Boyden, and
D Thomas, and
K Tymms
June 1994,
Clinical rheumatology,
D Barraclough, and
A Brook, and
P Brooks, and
K Boyden, and
D Thomas, and
K Tymms
December 1983,
The American journal of medicine,
